Early-stage biotech targeting muscle loss in patients with end-stage renal disease.
Industry: Health Care
First Day Return: -3.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/20/2014 |
Offer Price | $11.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 5.0 |
Deal Size ($mm) | $55 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/15/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $55 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Brisbane, CA, United States |
Founded | 2012 |
Employees at IPO | 15 |
Website www.atarabio.com |